Grifols Shares Rise on Potential Sale of Shanghai RAAS Stock for $1.5 Billion
14 Junio 2023 - 5:44AM
Noticias Dow Jones
By David Sachs
Shares in Grifols rose Wednesday after it said it is planning to
reduce its shareholding in Shanghai RAAS Blood Products and that it
expects to receive $1.5 billion from the move.
At 1010 GMT, shares in Grifols were up 8% to EUR11.96.
The Spanish pharmaceutical company said it has notified the
Chinese pharmaceutical firm and that the matter is still in
planning stages.
Grifols, which currently is the largest shareholder in Shanghai
RAAS, said it will remain a significant shareholder in the Chinese
company.
Write to David Sachs at david.sachs@wsj.com
(END) Dow Jones Newswires
June 14, 2023 06:29 ET (10:29 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Grifols (NASDAQ:GRFS)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Grifols (NASDAQ:GRFS)
Gráfica de Acción Histórica
De May 2023 a May 2024
